Scrambler Therapy for Post-Stroke Pain

PHASE4RecruitingINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

May 15, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Post Stroke Pain
Interventions
DEVICE

Scrambler Therapy

"Scrambler Therapy is a non-invasive neuromodulator treatment that focuses on relieving chronic pain through the sending of non-pain signals to the brain through the afferent pain sensory nerves. The signals given off by the scrambler therapy machine are intended to mimic neuronal action potentials through the synthesis of 16 unique waveforms that in combination forms a patient specific cutaneous electrostimulation to reduce pain. These information packets are then carried by the afferent C-fibers, an established system that modulates the sensations received instead of blocking them. The modulated signals are received as nonpainful and endogenous by the central nervous system."

DRUG

Standard Medication Management

Medications such as: gabapentin, duloxetine and Lyrica are all FDA approved for treatment of neuropathic pain, particularly that caused by diabetes.

Trial Locations (1)

21224

RECRUITING

Johns Hopkins Bayview Hospital, Baltimore

All Listed Sponsors
lead

Johns Hopkins University

OTHER